93197-2

LOINC 2.82

CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal

CYP4F2 c.1297G>A Geno Bld/T

Definition

  • The presence of the CYP4F2*3 (rs2108622) allele indicates that a patient who self-identifies as being of non-African ancestry may require a slightly increased warfarin dose than predicted by CYP2C9/VKORC1 alone.[PMID: 18250228] The rs2108622 variant (c.1297G>A) results in an amino acid substitution (valine to methionine) at position 433 (p.V433M).

Component

  • CYP4F2 gene.c.1297G>A

Specimen / system

  • Bld/Tiss

Class

  • MOLPATH.PHARMG

Property

  • Geno

Scale

  • Nom

Method

  • Molgen

Related names

  • Blood; CYP4F2 c.1297G>A; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NC_000019.10:g.15879621C>T; NC_000019.9:g.15990431C>T; NG_007971.2:g.23454G>A; NM_001082.4:c.1297G>A; Nominal; NP_001073.3:p.Val433Met; p.V433M; PCR; Point in time; Random; rs2108622; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Index terms

  • A
  • Blood
  • CYP4F2 c.1297G&gt
  • CYP4F2 gene.c.1297G>A
  • Molecular genetics
  • Molecular pathology
  • MOLPATH
  • MOLPATH.PHARMG
  • NC_000019.10:g.15879621C&gt
  • NC_000019.9:g.15990431C&gt
  • NG_007971.2:g.23454G&gt
  • NM_001082.4:c.1297G&gt
  • Nominal
  • NP_001073.3:p.Val433Met
  • p.V433M
  • PCR
  • Point in time
  • Random
  • rs2108622
  • T
  • Tissue
  • Tissue, unspecified
  • WB
  • Whole blood
  • Whole blood or Tissue